Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021.

Autor: Hoashi T; Department of Dermatology, Nippon Medical School, Tokyo, Japan., Ishikawa M; Department of Dermatology, Saitama Cancer Center, Saitama, Japan., Uehara J; Department of Dermatologic Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Oashi K; Department of Dermatology, Saitama Cancer Center, Saitama, Japan., Maeda S; Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan., Kato J; Department of Dermatology, Sapporo Medical University, Sapporo, Japan., Saruta H; Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan., Shichinohe R; Department of Plastic and Reconstructive Surgery, Teine Keijinkai Hospital, Sapporo, Japan., Ohashi R; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan., Nakamura Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Koga H; Department of Dermatology, Shinshu University, Matsumoto, Japan., Sugaya M; Department of Dermatology, International University of Health and Welfare, Narita, Japan.
Jazyk: angličtina
Zdroj: The Journal of dermatology [J Dermatol] 2024 Apr; Vol. 51 (4), pp. e90-e105. Date of Electronic Publication: 2024 Jan 24.
DOI: 10.1111/1346-8138.16944
Abstrakt: To summarize the current therapies for skin cancers, the Japanese Skin Cancer Society issued the first guidelines for skin cancers, including melanoma, squamous cell carcinoma, basal cell carcinoma (BCC), and extramammary Paget's disease, in 2007. These guidelines were revised in 2015. Herein, we present the English version of the 2021 edition of the Japanese clinical guidelines for BCC. In the latest edition, all procedures were performed according to the Grading of Recommendations, Assessment, Development and Evaluation systems. The clinical questions that could not be answered were selected for further analysis. A comprehensive literature search, systematic review, and recommendations for each clinical question were determined by a multidisciplinary expert panel comprising dermatologists, a plastic and reconstructive surgeon, and a pathologist. Surgical resection is the gold-standard therapy of BCC. Radiotherapy or topical treatments, other than surgical resection, have been used in some cases. Patients with unresectable or metastatic BCC require systemic therapy. Novel agents, such as immune response modifiers or hedgehog pathway inhibitors, are emerging worldwide for the treatment of BCC. Based on these viewpoints, four relevant clinical questions regarding, surgical resection, radiotherapy, topical treatment, and systemic therapy, were raised in this report that aims to help clinicians select suitable therapies for their patients.
(© 2023 Japanese Dermatological Association.)
Databáze: MEDLINE
Externí odkaz: